Stability tests prompt Bausch & Lomb ReNu recall

Substandard quality identified in routine testing and reports of sensitivity have prompted to Bausch & Lomb to make a two-part precautionary recall of its ReNu contact lens solution in Europe and the Middle East.

Part one involves one lot of 120-milliliter ReNu MultiPlus multi-purpose solution. The company says it received "a small number of reports about sensitivity issues related to this lot," according to a press report. The product was distributed in Croatia, Dubai, Hungary, Slovenia, Romania, Turkey and Saudi Arabia.

In part two, Bausch & Lomb is recalling some lots of both the ReNu and ReNu MultiPlus solutions in Europe and the Middle East. "They are not meeting our quality expectations," the company said in the report. Stability monitoring showed sub-par  performance.

The recalled products show no indication of safety or efficacy issues, the company says.

- here's the article

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.